Valuation: Prince Pharmaceutical Co., Ltd.

Market Cap 1.09B 33.98M 29.09M 27.14M 24.91M 46.8M 3.25B 47.72M 322M 126M 1.63B 128M 125M 5.39B P/E 2024
-15x
P/E 2025 11.9x
Enterprise Value 1.35B 42.41M 36.31M 33.88M 31.09M 58.42M 4.06B 59.57M 402M 157M 2.03B 159M 156M 6.73B EV / Sales 2024
1.68x
EV / Sales 2025 1.33x
Free-Float
33.7%
Yield 2024 *
-
Yield 2025 1.61%
1 day+4.77%
1 week-1.98%
Current month-0.17%
1 month-4.97%
3 months+2.24%
6 months+1.19%
Current year-4.66%
1 week 26.05
Extreme 26.05
29.7
1 month 26.05
Extreme 26.05
33.05
Current year 26.05
Extreme 26.05
33.05
1 year 25.2
Extreme 25.2
35.85
3 years 18.5
Extreme 18.5
40.9
5 years 18.5
Extreme 18.5
75.2
10 years 18.5
Extreme 18.5
75.2
Manager TitleAgeSince
Chief Executive Officer - 2021-12-09
Director of Finance/CFO - 2008-06-01
Chief Tech/Sci/R&D Officer - 1991-01-31
Director TitleAgeSince
Chairman - -
Director/Board Member - 2023-01-17
Director/Board Member - 2023-01-17
Change 5-day change 1-year change 3-year change Capi.($)
+4.77%-1.98%+16.73%-21.97% 32.43M
-1.52%-1.56%+17.93%+73.23% 12.89B
-5.37%+18.70%-0.14%+376.11% 10.72B
-2.21%-3.57%-22.12%-49.74% 2.48B
+0.91%+1.40%-12.43%-6.63% 1.49B
+0.04%+0.18%+23.82%+78.62% 1.38B
+2.59%+1.46%+36.27%-20.87% 1.27B
+0.05%-2.14%-73.55%-73.34% 1.22B
-1.28%-6.61%-42.63% - 1.06B
-0.82%-3.18%-62.72%-67.93% 972M
Average -0.29%+0.00%-11.88%+31.94% 3.35B
Weighted average by Cap. -2.38%+1.83%+1.19%+146.96%

Financials

2024 2025
Net sales 690M 21.6M 18.5M 17.26M 15.84M 29.76M 2.07B 30.34M 205M 79.81M 1.04B 81.12M 79.35M 3.43B 1.06B 33.07M 28.31M 26.42M 24.24M 45.55M 3.16B 46.44M 313M 122M 1.59B 124M 121M 5.25B
Net income -53.54M -1.68M -1.44M -1.34M -1.23M -2.31M -160M -2.35M -15.89M -6.19M -80.38M -6.29M -6.16M -266M 96.32M 3.02M 2.58M 2.41M 2.21M 4.15M 289M 4.24M 28.58M 11.14M 145M 11.32M 11.08M 479M
Net Debt 358M 11.21M 9.6M 8.95M 8.22M 15.44M 1.07B 15.74M 106M 41.41M 537M 42.08M 41.17M 1.78B 269M 8.43M 7.22M 6.74M 6.18M 11.62M 807M 11.85M 79.93M 31.16M 404M 31.67M 30.98M 1.34B
Logo Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co Ltd is a Taiwan-based Company engaged in the manufacture and sale of health food and ingredients. The Company's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs. The health food business is mainly engaged in the original equipment manufacturer (OEM) and original design manufacturer (ODM) of health food products, providing a series of integrated services from product formulation design, research and development to the production and packaging of various dosage forms. The Company sells its products mainly in domestic and overseas markets, including Japan and Korea.
Employees
216
Date Price Change Volume
26-08-20 NT$29.65 +4.77% 14,339
26-08-20 NT$28.30 -0.35% 20,080
26-08-19 NT$28.40 +0.35% 75,186
26-08-18 NT$28.30 -2.75% 52,114
26-08-17 NT$29.10 -0.17% 3,010
  1. Stock Market
  2. Stocks
  3. 6935 Stock